Design, Synthesis, and Biological Evaluation of PKD Inhibitors

• Main Authors: Marie-Céline Frantz (Author), Karla Bravo-Altamirano (Author), Courtney R. LaValle (Author), Manuj Tandon (Author), Stephanie Leimgruber (Author), Elizabeth R. Sharlow (Author), John S. Lazo (Author), Q. Jane Wang (Author), Peter Wipf (Author), Kara M. George (Author)
• Format: Book
• Published: MDPI AG, 2011-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Protein kinase D (PKD) belongs to a family of serine/threonine kinases that play an important role in basic cellular processes and are implicated in the pathogenesis of several diseases. Progress in our understanding of the biological functions of PKD has been limited due to the lack of a PKD-specific inhibitor. The benzoxoloazepinolone CID755673 was recently reported as the first potent and kinase-selective inhibitor for this enzyme. For structure-activity analysis purposes, a series of analogs was prepared and their in vitro inhibitory potency evaluated.

Item Description

10.3390/pharmaceutics3020186
1999-4923